trending Market Intelligence /marketintelligence/en/news-insights/trending/TTQpwlNf7ylGfvUuZOtmkA2 content esgSubNav
In This List

Zomedica Pharmaceuticals completes $4.3M common share placement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Zomedica Pharmaceuticals completes $4.3M common share placement

Ann Arbor, Mich.-based Zomedica Pharmaceuticals Corp. completed a private placement of 2,815,789 common shares priced at $1.52 each.

The veterinary diagnostic and pharmaceutical company raised aggregate gross proceeds of $4.3 million from the placement of shares to accredited investors.

Zomedica plans to use the proceeds from the offering to fund its obligations under a development and supply deal with Qorvo Biotechnologies.